SPP1 and melanoma: Studies have previously shown that stromal SPP1 promotes cancer cell survival and enhances invasion behavior in glioma (Lu et al., 2012), prostate cancer (Pang et al., 2019), and melanoma (Kale et al., 2015), suggesting a direct effect of SPP1 on tumor cells.